Revolution Medicines, Inc. (RVMD) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGS. Market cap 40.32B USD. 52-week range 47.28 to 224.31 USD. Data as of 2026-10-09.
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its ...